Compare Ishares Msci Brazil ETF (EWZ) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ishares Msci Brazil ETF vs Recursion Pharmaceuticals Inc — how do they compare? Ishares Msci Brazil ETF trades at $35.48, while Recursion Pharmaceuticals Inc trades at $3.17 (market cap $1.75B). The key difference: Ishares Msci Brazil ETF is trading nearer its 52-week high, Recursion Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| EWZ | RXRX | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $41.75 | $6.79 |
52-Week Low | $26.52 | $2.84 |
Market Cap | — | $1.75B |
Enterprise Value | — | $1.17B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWZ (iShares MSCI Brazil ETF) trades at $35.365, down 1.85% today but maintains a bullish technical outlook with 15 buy signals versus 4 sell signals. The ETF has gained approximately 11% year-to-date, benefiting from Brazil's monetary easing cycle and commodity strength. Recent news highlights Brazil's $9.92 billion Eco Invest auction and export regulation adjustments to meet EU requirements, supporting economic momentum.
The outlook for EWZ remains positive as Brazil's central bank continues rate cuts from historically high levels, creating favorable conditions for equities. Key risks include dependency on commodity prices and potential economic volatility. Analyst sentiment leans bullish with expectations of further upside from monetary policy support and attractive valuations in Brazilian markets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
